Cargando…
Risk and mitigation actions for clinical trials during COVID-19 pandemic (RiMiCOPa)
The COVID-19 virus diffusion is, nowadays, global and any clinical trial is potentially affected by the direct and indirect consequences of the COVID-19 during the pandemic. Any step, from protocol design to result's disclosure, needs to be revised to assess the impact of the COVID-19 on the st...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703225/ https://www.ncbi.nlm.nih.gov/pubmed/33283069 http://dx.doi.org/10.1016/j.conctc.2020.100682 |